Aton Biotech is a fast-growing Contract Development and Manufacturing Organization (CDMO) specializing in biopharmaceuticals. They offer end-to-end services, including cell line development, process and analytical methods development, and GMP manufacturing. Aton Biotech's expertise extends to developing mammalian-expressed monoclonal antibodies, fusion proteins, bispecific antibodies, and antibody-drug conjugates (ADCs). The company operates two R&D and manufacturing sites in Shanghai, compliant with cGMP standards from NMPA, EMA, and FDA, enabling clients to bring innovative biological drugs from concept to market efficiently.
Visit Company Website
